Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALPRAZOLAM Cause Chronic kidney disease? 37 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Chronic kidney disease have been filed in association with ALPRAZOLAM (Alprazolam). This represents 0.1% of all adverse event reports for ALPRAZOLAM.

37
Reports of Chronic kidney disease with ALPRAZOLAM
0.1%
of all ALPRAZOLAM reports
0
Deaths
19
Hospitalizations

How Dangerous Is Chronic kidney disease From ALPRAZOLAM?

Of the 37 reports, 19 (51.4%) required hospitalization, and 1 (2.7%) were considered life-threatening.

Is Chronic kidney disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALPRAZOLAM. However, 37 reports have been filed with the FAERS database.

What Other Side Effects Does ALPRAZOLAM Cause?

Drug abuse (8,827) Toxicity to various agents (7,157) Completed suicide (4,873) Drug ineffective (4,040) Overdose (2,967) Drug dependence (2,743) Somnolence (2,461) Intentional overdose (2,389) Death (2,317) Suicide attempt (2,313)

What Other Drugs Cause Chronic kidney disease?

OMEPRAZOLE (35,759) ESOMEPRAZOLE (35,281) LANSOPRAZOLE (32,517) PANTOPRAZOLE (28,127) DEXLANSOPRAZOLE (15,973) EMTRICITABINE\TENOFOVIR DISOPROXIL (10,248) TENOFOVIR DISOPROXIL (7,230) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (5,861) RABEPRAZOLE (4,773) ESOMEPRAZOLE\NAPROXEN (2,714)

Which ALPRAZOLAM Alternatives Have Lower Chronic kidney disease Risk?

ALPRAZOLAM vs ALPROSTADIL ALPRAZOLAM vs ALTEPLASE ALPRAZOLAM vs ALTERNARIA ALTERNATA ALPRAZOLAM vs ALTHIAZIDE ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE

Related Pages

ALPRAZOLAM Full Profile All Chronic kidney disease Reports All Drugs Causing Chronic kidney disease ALPRAZOLAM Demographics